Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • PrimeView
  • Published:

Nanotechnology-based mRNA vaccines

Nature Reviews Methods Primers volume 3, Article number: 64 (2023) Cite this article

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

This PrimeView highlights the production of nanotechnology-based mRNA vaccines, with a focus on their use to prevent infectious disease and in targeting tumours.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nanotechnology-based mRNA vaccines. Nat Rev Methods Primers 3, 64 (2023). https://doi.org/10.1038/s43586-023-00256-5

Download citation

  • Published:

  • DOI: https://doi.org/10.1038/s43586-023-00256-5

Search

Advanced search

Quick links